Genmab — Juni 2017

[Helge_LarsenPI-redaktør]

God Morgen.

[JKY_VH]

God morgen

[transalp]

Go morgen...:)

[bibob]

God morgen

[bongobob]

Go morn. Duobody BCMAxCD3 phase 1 har startet recruitng: https://clinicaltrials.gov/ct2/show/NCT03145181?term=JNJ-64007957&rank=1

[Sukkeralf]

Dejligt og hurtigt

[Darvin]

Go morn og tak Bongo og gen med sidste nye

[JKY_VH]

tak bongo

[bongobob]

Her er lidt resultater fra Dara i AL: http://www.bloodjournal.org/content/early/2017/06/14/blood-2017-01-763599

[bibob]

Tak for nyhed Bongo. Det var opløftende.

[bongobob]

"Daratumumab is a highly effective agent that produced rapid and deep hematologic responses without unexpected toxicity in our cohort of heavily pretreated AL patients"

[bongobob]

Jeg synes vi har set det før

[JKY_VH]

[bongobob]

Der er gang i den i dag. GEN har taget et mege bredt patent på AXL. Det ser ud til de har fået det hele med fra inhibitor til diagnostic kit: http://www.freshpatents.com/-dt20170608ptan20170157250.php

[bongobob]

meget

[E_L]

On that patent, i see "PCT Filed: Jul. 10, 2015", so i am guessing it took 2 years to get patent approved...?

[E_L]

and only after approval they can start their clinical trials i imagine...

[bongobob]

Yes but you still have rights when "Patent pending". I don't think it is a show stopper

[KWC]

Nogen der har futures på Genmab ?

[E_L]

something else, the new clinical trial gentogen posted last night is great, but Waldenström is a rare disease, with only about 1,500 cases per year in the United States